One particularly intriguing character revealed in the latest episode is Yamato Endo. Yamato Endo is a key antagonist in the Wind Breaker series and serves as the main overarching antagonist of the ...

Editor’s Note: There will be some mild spoilers regarding the four stories in the The Four Lives Remain: Tatsuya Endo Before Spy x Family manga below. The Four Lives Remain: Tatsuya Endo Before ...

Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S. footprint. The companies said Thursday they reached a definitive ...

Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with the ...

(RTTNews) - Specialty pharmaceutical companies Mallinckrodt plc and Endo, Inc. announced Thursday that they have entered into a definitive agreement to combine in a stock and cash transaction.

Mallinckrodt Pharmaceuticals plc and Endo Inc. said Thursday they are combining as part of a stock-and-cash deal with an enterprise value of $6.7 billion that will give both companies a roughly 50 ...

Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments. The agreement will give ...

Net Leverage of Approximately 2.3x Expected at Close Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the close of the ...

Liverpool's Wataru Endo and Brighton's Kaoru Mitoma were on Thursday named in Japan's squad as they look to become the first team to qualify for the 2026 World Cup. The runaway Asian qualifying ...

Mallinckrodt and Endo said they will merge through a $6.7 billion cash and stock deal creating a combined company that will be intent on bouncing back from their troubled recent histories ...

MALVERN, Pa., March 11, 2025 /CNW/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals ...